Poster Abstracts • OFID 2018:5 (Suppl 1) • S457 pedal edema (31.4%), pallor (39.4%), vomiting (26.7%) were most common findings apart from fever and dyspnoea. Nine of them had bleeding manifestations. The most common diagnosis was Scrub typhus (32.4%), followed by coinfections (13.7%), H1N1 influenza in 8.8% cases. 30.4% patients did not fall into any diagnostic criteria. Leptospira, dengue and Malaria were present in 4.4 and 2 cases, respectively. A total of 50 patients were intubated and ventilated during their stay in the hospital. APACHE 2 score was observed to better predict mortality than SOFA score. Factors which predicted mortality were male sex, age >45 years, invasive ventilation and low GCS Conclusion. Fever and ARDS have more incidence among young females and occur significantly during post monsoon season. Scrub typhus constituted the majority of fever with ARDS cases followed by H1N1. Coinfections were common cause of Fever with ARDS. Predictors of mortality were male gender, old age, long duration of invasive ventilation, higher serum procalcitonin levels and low GCS at admission. APACHE 2 score was a better predictor of mortality than SOFA score.
Background. Pneumonia is the most common hospital-acquired infection; most cases occur in nonventilated patients, yet the majority of hospitals do not track nonventilator hospital-acquired pneumonia (NV-HAP) given the complexity and subjectivity of CDC's current surveillance definition and large number of patients at risk. We sought to develop objective, electronically computable surveillance definitions for NV-HAP to facilitate routine surveillance.
Methods. We developed ten candidate definitions based on different combinations of 6 clinical indicators and applied them to 60,725 adult admissions of ≥3 days to Brigham and Women's Hospital between July 2015 and June 2017. Potential indicators included worsening oxygenation, new antibiotics given for ≥3 days, fever, abnormal white blood cell count, chest imaging orders, and respiratory cultures on hospital day ≥3. Worsening oxygenation was defined as ≥2 days of decreased oxygen saturation or escalation in supplemental oxygen following ≥2 days of stable oxygenation. We calculated incidence and mortality rates for each definition. We then matched each case with up to four controls on the basis of clinical service and duration of hospitalization and measured associations between each definition and increased mortality and length of stay, adjusting for patients' demographics, comorbidities, and severity of illness.
Results. The incidence of NV-HAP ranged from 7.6 events per 100 admissions with the least restrictive definition (worsening oxygenation alone), to 0.7 events per 100 admissions (worsening oxygenation, fever or leukocytosis, and new antibiotics), to 0.2 events per 100 admissions (all signs present). Crude mortality rates ranged from 17% to 30%. Odds ratios for mortality in cases vs. controls ranged from 4.3 (95% CI 3.8-5.0) to 8.5 (95% CI 6.3-11.4). Odds ratios for days-until-discharge in cases vs. controls ranged from 1.7 (95% CI 1.5-1.9) to 2.1 (95% CI 2.0-2.2).
Conclusion. We demonstrate the feasibility of applying electronically computable objective surveillance definitions for NV-HAP. These definitions yield incidence and mortality rates comparable to existing estimates based on manual surveillance Methods. Further work is needed to better understand the clinical correlates of these events and their potential preventability.
Disclosures. Background. Inconsistent intra-individual microbiota between upper and lower respiratory niches has been reported among infants with Cystic Fibrosis (CF). We aimed to investigate the concordance between the bacterial community composition of 20 oropharyngeal (OP) samples and 20 corresponding sputa, collected from children with CF above one year of age.
Methods. As part of the"'cystic fibrosis, respiratory viruses, intracellular bacteria and fastidious organisms'' (MUCOVIB) project, all children under 18 years of age with diagnosed CF were recruited into a swiss multicentric study. Respiratory samples included OP swabs collected from all children in addition to sputa collected from those able to expectorate. Sequencing and data analysis of amplicons of the V3-V4 variable region of the 16S rRNA-encoding gene were performed. Paired-read were assembled with PANDAseq and clustered into operational taxonomic units (OTUs) using vsearch and assigned to taxonomical ranks using Qiime and the EzBioCloud database. Nonmetric multidimensional scaling, ANOVA and PERMANOVA were used to analyze the bacterial diversity in upper and lower respiratory niches.
Results. Fifty-eight children, of whom 29 (50%) provided 51 sputa samples. From these 29, 10 patients (40 samples) provided concomitant OP and sputa samples collected during the same visit. Equivalent species diversity (alpha-diversity; Shannon index) was documented from both upper and lower samples (P = 0.26). In most cases, hierarchical clustering based on OTU presence/absence clustered upper and lower samples from the same patient and during the same visit, thus suggesting a signature microbiota in most patients. A similar variance of bacterial microbiota was observed in upper and lower respiratory niches (P = 0.9422), with some differences in species composition.
Conclusion. Our preliminary findings conducted on a small subset of patients, suggested a good intra-individual concordance of the microbiota in upper and lower respiratory niches, thus suggesting that OP swabs could be used as proxy to measure bacterial biodiversity among children with CF unable to expectorate.
Disclosures. Background. Pseudomonas aeruginosa (PA) is known to cause infection in the intensive care unit (ICU) and contribute to substantial morbidity and mortality. The objectives of this study were to describe the epidemiology, antimicrobial resistance and outcomes in critically ill patients with pseudomonal infection.
Methods. Patients with PA isolated during ICU admission from 2013-2016 were identified using provincial microbiology data. Patients were classified as colonized or infected. Those with infection were reviewed for source of infection, patient characteristics, antimicrobial susceptibilities, appropriateness of empiric antimicrobial therapy and 30-day mortality. Independent predictors of mortality were identified using multivariable logistic regression.
Results. A total of 196 unique patients were culture-positive for PA. 140 (71%) were infected and included for analysis. Mean patient age was 55.4 years (18.4 SD) and 62% were male. Admission categories included medical (71%), surgical (20%), and trauma or neurological (9%). Mean APACHE II score at the time of ICU admission was 19.4 (9.8 SD). One hundred and twenty-six (90%) patients required invasive mechanical ventilation, 102 (73%) vasopressor support and 27 (19%) new initiation of renal replacement therapy. Thirty-two (23%) died within 30 days of ICU admission. The median ICU length of stay was 13 days . Median time to infection was 1 day (IQR 0-9). Sources were respiratory (66%) followed by skin/soft tissue (11%), urinary (10%), and blood (5%). Twenty (14%) isolates were multi-drug-resistant (MDR) and six (4%) were extensively drug resistant (XDR). There were no pan-resistant isolates. One hundred and one (52%) of infections were nosocomial. Empiric antimicrobial therapy was effective in 97 (69%) cases. On multivariable analysis liver disease (aOR 6.2, 95% CI 1.5-25.7; P = 0.01), malignancy (aOR 5.0, 95% CI 1.5-17.3; P = −0.01) and higher APACHE II score at the time of admission (aOR 1.1, 95% CI 1.0-1.1; P = 0.02), were independently associated with 30-day mortality.
Conclusion. PA in the ICU is associated with substantial mortality and is most commonly isolated from the respiratory tract. Existing malignancy, liver disease and higher APACHE II score at admission were independently associated with mortality.
Disclosures. All authors: No reported disclosures. Background. Antibiotic prescription rates for treating exacerbations of chronic obstructive pulmonary disease (COPD) have been reported as high as 90% in the United States. Research has shown that over 50% of COPD exacerbations are due to viral etiologies. Elevations in procalcitonin (PCT) levels can be seen in bacterial infections and can help guide the need for antimicrobial therapy. The goal of this study is to evaluate the impact of PCT on antibiotic use in patients with COPD exacerbations.
Evaluating the Impact of Procalcitonin on Antibiotic Utilization in Chronic
Methods. We conducted a retrospective, pre-and post-intervention study. Patients at least 18 years of age, with a diagnosis of COPD exacerbation, and had a PCT level drawn within 24 hours of admission were included. Exclusion criteria included patients presenting with severe trauma, sepsis, bacterial pneumonia, patients who required invasive mechanical ventilation, and patients with an initial admission to the ICU. The primary outcome was antimicrobial duration of therapy. Secondary outcomes included hospital length of stay (LOS), respiratory-related 30-day readmission rates, and treatment failure defined as ICU admission, requirement of invasive mechanical ventilation, or death.
Results. A total of 139 patients were evaluated with 64 and 75 patients in the pre-and post-intervention cohorts, respectively. PCT guidance was associated with a significant reduction in number of antibiotic days of therapy (7.1 days vs. 2.4 days; P < 0.001). A trend in decreasing LOS was observed but did not reach statistical
